49 results
SC TO-C
EX-99.1
INVA
Innoviva Inc
11 Jul 22
Information about tender offer
3:46pm
company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and La Jolla Pharmaceutical Company (Nasdaq: LJPC … ), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today
8-K
EX-99.1
INVA
Innoviva Inc
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, and La Jolla Pharmaceutical Company (Nasdaq: LJPC … ), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today
SC TO-C
EX-99.2
ETTX
Entasis Therapeutics Holdings Inc.
23 May 22
Information about tender offer
8:54pm
companies with innovative healthcare assets in areas with significant unmet medical needOur team has deep industry expertise across investing, operations … company with a portfolio of royalties and a growing portfolio of innovative healthcare investments and assetsRoyalty portfolio consists of respiratory
SC TO-C
EX-99.4
ETTX
Entasis Therapeutics Holdings Inc.
23 May 22
Information about tender offer
8:54pm
in developing innovative anti-infective treatments for patients with critical unmet medical needs.
Bringing new infectious disease therapeutics … protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
SC TO-T/A
EX-99
INVA
Innoviva Inc
22 Aug 22
Third party tender offer statement (amended)
9:08am
. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today … successfully completed its acquisition of La Jolla, which is dedicated to the commercialization of innovative therapies that improve outcomes in patients
8-K
EX-99
7htsg
22 Aug 06
Theravance Announces Positive Results In Phase 3 Telavancin Complicated Skin and Skin Structure Infection Program
12:00am
8-K
EX-99.3
188e7u kh1qqa
23 May 22
Tender and Support Agreement
8:51pm
SC TO-C
EX-99.3
p4awsgkqzi
23 May 22
Information about tender offer
8:53pm
SC TO-C
EX-99.3
gapqfnu58mxmyjfbo
23 May 22
Information about tender offer
8:54pm
8-K
EX-99.1
y4oob
14 Sep 22
Regulation FD Disclosure
5:22pm
SC TO-C
EX-99.1
lb4vw
23 May 22
Information about tender offer
8:54pm
8-K
EX-99.1
k9atrud4ysc5ufs dn1
7 Apr 22
Regulation FD Disclosure
5:09pm
8-K
EX-99
ise6iwv9ypu vghm
15 Sep 11
Other Events
12:00am
8-K
EX-99
xw6j3y48817
14 Sep 09
Other Events
12:00am
8-K
EX-99
aymtu14 ylsqi4
20 Feb 07
Other Events
12:00am
8-K
EX-99
qpvtv6tew rcnfwepu
16 Oct 12
Other Events
12:00am
8-K
EX-99
bitysntmlh tui
8 Dec 06
Other Events
12:00am
8-K
EX-99.1
91ye4lxv1
6 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
yllm2z19lgz4o70r67to
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm